| Literature DB >> 34914611 |
Maria Jesus Vinolo Gil1,2,3, Gloria Gonzalez-Medina1,3, David Lucena-Anton1, Veronica Perez-Cabezas1, María Del Carmen Ruiz-Molinero1,3, Rocío Martín-Valero4.
Abstract
BACKGROUND: Augmented reality (AR) is a rapidly expanding technology; it comprises the generation of new images from digital information in the real physical environment of a person, which simulates an environment where the artificial and real are mixed. The use of AR in physiotherapy has shown benefits in certain areas of patient health. However, these benefits have not been studied as a whole.Entities:
Keywords: augmented reality; functionality; physical therapy; rehabilitation
Year: 2021 PMID: 34914611 PMCID: PMC8717132 DOI: 10.2196/30985
Source DB: PubMed Journal: JMIR Serious Games Impact factor: 4.143
Figure 1Flow diagram. Graphical representation of the process of search and selection of studies.
Main characteristics of the study interventions.
| Study | Sample | Age (years), mean (SD) | Study population | Intervention | Frequency of treatment (times/week) | Session time (minutes) | Total time of the intervention | Measurement instrument | Outcome | Results |
| Colomer et al [ | 30 | 58.3 (10.1) | Stroke | IGa: reverse study—A-B-A; A: conventional physical therapy program; B: ARb | 3-5 | 45 | 12 weeks | Wolf motor function test, box and block test, 9-hole plug test, and Intrinsic Motivation Inventory | Elbow flexion and extension, wrist flexion and extension, finger flexion and extension, and grabbing different objects |
Significant improvement in arm function and finger dexterity High levels of interest, motivation, and enjoyment |
| Lee et al [ | 21; CGc: 11; IG: 11 | Not specified | Stroke | CG: general physical therapy program; IG: general physical therapy program+AR-based postural control program | CG: 5; IG: 3 | 30 | CG: 4 weeks; IG: 8 weeks | TUGd, BBSe, spatial-temporal parameters (GAITRite), and dynamometer | Gait, balance, and muscle strength |
Improvements in walking speed, balance and cadence, stride length, and stride length of paretic and nonparetic sides |
| Jung et al [ | 10; CG: 5; IG: 15 | CG: 57.80 (10.23); IG: 58.40 (8.26) | Stroke | CG: FESf; IG: AR-based FES | 3 | 20 | 4 weeks | Surface EMGg machine, electronic goniometer, and manual muscle tester | Muscle activation, ankle range of motion, and muscle strength |
Improved muscle activation in GCMhand TSAi Improved muscle strength in dorsiflexion and plantar flexion |
| Kim et al [ | 28; group 1: 9; group 2: 10; group 3: 9 | Group 1: 47.4 (8.4); group 2: 51.5 (12.9); group 3: 49.1 (11) | Stroke | Group 1: treadmill walking with EFSj and AR therapy; group 2: treadmill walking with EFS therapy; group 3: gait on treadmill walking | 3 | 20 | 8 weeks | BBS and TUG | Muscle strength, balance, and gait |
Muscle strength increased significantly in groups 1 and 2. Balance and gait showed significant improvements in all groups. |
| Rothgangel et al [ | 75; group 1: 25; group 2: 26; CG: 24 | 61.1 (14.2) | Lower limb amputation | Group 1: mirror therapy+ AR teleprocessing; group 2: mirror therapy+self-administered mirror therapy; CG: sensory-motor exercises | Not specified | 30 | Group 1: 10 weeks; group 2: 10 weeks; CG: 10 weeks | NRSk inventory of neuropathic pain symptoms, Patient-specific Functional Scale, EuroQol 5 Dimensions, Overall Perceived Effect Scale, and pain Self-Efficacy Questionnaire | Intensity, frequency, and duration of phantom pain |
AR had no additional effects compared with the other groups. |
| Ortiz-Catalán et al [ | 14 | 50.3 (13.9) | Upper limb amputation | IG: motor execution in AR, game series; use of a virtual member in different tasks | 2 | 120 | 12 sessions | NRS pain rating index, Weighted Scale of Pain Distribution, and study-specific frequency scale for each session | Intensity, frequency, duration, and quality of phantom limb pain (upper) |
Clinical and statistical improvements in all phantom limb pain metrics |
| Lee et al [ | 30; group 1: 10; group 2: 10; group 3: 10 | Women; group 1: 72.6 (2.67); group 2: 75.8 (5.47); group 3: 76.4 (5.54) | Older adults | Group 1: AR+Otagol; group 2: yoga; group 3: exercises at home | 3 | 60 | 12 weeks | Strength of knee flexor, extensor, and ankle flexor muscles; footprint; static and dynamic load distribution; and MFSm | Muscle strength, balance, and risk of falling |
Group 1, group 2, and group 3 had improved strength. The AR group improved significantly in balance and in the fall scale. |
| Yoo et al [ | 21; group 1: 10; group 2: 11 | Women; group 1: 72.9 (3.41); group 2: 75.6 (5.57) | Older adults | Group 1: AR +Otago exercises; group 2: Otago exercises | 3 | 50 | 12 weeks | Gait parameters, BBS, and FES-In | Gait functionality, balance, and risk of falling |
Group 1 had significant differences in gait and balance parameters greater than group 2. Group 1 had significant differences in fall prevention. |
| Ku et al [ | 36; CG: 18; IG: 18 | CG: 65 (4.77); IG: 64.7 (7.27) | Older adults | CG: physical fitness program; IG: training with 3D-AR system | 3 | 30 | 4 weeks | BBS, TUG, FACo, MBIp, Fugl-Meyer lower limb subscale, Fugl-Meyer motor coordination, Fugl-Meyer motor score, and balance (Tetrax posturography) | Lower limb balance and lower limb mobility |
Improved stability index with interaction between BBS and TUG Improvement in fall risk Improvement of the posturographic index Improved weight distribution index |
| Jeon et al [ | 27; CG: 13; IG: 14 | CG: 72.71 (3.64); IG: 72.77 (3.79) | Older adults | CG: no exercise; IG: AR-based exercise | 3 | 30 | 12 weeks | Stadiometer, BIAq, hand dynamometer, SFTr, and ESEs | Muscle mass, muscle function, physical performance, and exercise self-efficacy |
Improved ASMt, SMIu, gait speed, SFT in chair stand test, 2MSTv, and self-efficacy |
| Janssen et al [ | 16 | Median: 69 | Parkinson disease | Experimental condition: series of 180° turns with AR visual cues displayed through a HoloLens; 2 control conditions: with auditory cues and without any cues | 1 session | N/Aw | 1 session | PTFx, mean number, and duration of FOGy episodes; maximum medial COMz deviation, maximum head-pelvis separation, and time to maximum head-pelvis separation; cadence, peak angular velocity, stride time, coefficient of variation, step height, and turn time | FOG parameters, axial kinematics, scaling, and timing of turning |
AR visual cues did not reduce the PTF ( All FOG parameters were higher with AR visual cues than with auditory cues (PTF, |
aIG: intervention group.
bAR: augmented reality.
cCG: control group.
dTUG: Timed Up and Go.
eBBS: Berg Balance Scale.
fFES: functional electric stimulation.
gEMG: electromyogram.
hGCM: medial and lateral gastrocnemius.
iTSA: tibialis anterior.
jEFS: electrical functional stimulation.
kNRS: Numerical Pain Rating Scale.
lOtago: Strength and Balance Training Program for Seniors.
mMFS: Morse Fall Scale.
nFES-I: Short Falls Efficacy Scale–International.
oFAC: functional ambulation category.
pMBI: Modified Barthel Index.
qBIA: Bioelectrical Impedance Analysis (Inbody 720, Biospace).
rSFT: senior fitness test.
sESE: exercise self-efficacy.
tASM: appendicular skeletal muscle mass.
uSMI: skeletal muscle index.
v2MST: 2-minute step test.
wN/A: not applicable.
xPTF: percentage time frozen.
yFOG: freezing of gait.
zCOM: center of mass.
Evaluation of the methodological quality according to the PEDro scalea.
| Study | Item 1b | Item 2c | Item 3d | Item 4e | Item 5f | Item 6g | Item 7h | Item 8i | Item 9j | Item 10k | Item 11l | Score (out of 10) |
| Colomer et al [ | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 4 |
| Lee et al [ | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 7 |
| Jung et al [ | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 6 |
| Kim et al [ | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 4 |
| Rothgangel et al [ | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 8 |
| Ortiz-Catalán et al [ | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 7 |
| Lee et al [ | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 4 |
| Yoo et al [ | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5 |
| Ku et al [ | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
| Jeon et al [ | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 |
| Janssen et al [ | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
a1=yes and 0=no.
bChoice criteria specified; did not add up in the final computation.
cRandom assignment.
dCovert assignment.
eBaseline similarity.
fSubject blinding.
gTherapist blinding.
hEvaluator blinding.
iGreater than 85% follow-up for at least 1 key outcome.
jIntention-to-treat analysis.
kStatistical comparison between groups for at least 1 key outcome.
lPoint measures and variability for at least 1 key outcome.
Grades of recommendation according to the Scottish Intercollegiate Guidelines Network scale.
| Study | Grade of recommendation |
| Colomer et al [ | B |
| Lee et al [ | A |
| Jung et al [ | B |
| Kim et al [ | B |
| Rothgangel et al [ | A |
| Ortiz-Catalán et al [ | B |
| Lee et al [ | B |
| Yoo et al [ | B |
| Ku et al [ | A |
| Jeon et al [ | B |
| Janssen et al [ | B |
Risk of bias.
| Author | Criteria (risk) | ||||||
|
| 1a | 2b | 3c | 4d | 5e | 6f | 7g |
| Colomer et al [ | High | High | High | High | Low | Unclear | Unclear |
| Lee et al [ | Low | High | High | Low | Low | Unclear | Unclear |
| Jung et al [ | Low | Unclear | High | High | Low | Unclear | Unclear |
| Kim et al [ | Unclear | High | High | High | Low | Unclear | Unclear |
| Rothgangel et al [ | Low | High | High | Low | Low | Unclear | Unclear |
| Ortiz-Catalán et al [ | Low | High | High | Low | Low | Unclear | Unclear |
| Lee et al [ | Unclear | High | High | Unclear | Low | Unclear | Unclear |
| Yoo et al [ | Unclear | High | High | Low | Low | Unclear | Unclear |
| Ku et al [ | Low | Low | High | Low | Low | Unclear | Unclear |
| Jeon et al [ | Low | Unclear | High | High | Low | Unclear | Unclear |
| Janssen et al [ | High | High | High | High | Low | Unclear | Unclear |
aRandom sequence generation (selection bias).
bAllocation concealment (selection bias).
cBlinding of participants and personnel (performance bias).
dBlinding of outcome assessment (detection bias).
eIncomplete outcome data (attrition bias).
fSelective reporting (reporting bias).
gOther bias.
Data used for the meta-analysis.
| Study and outcome | SMCa | Correlations between pre- and postintervention means | SD prediction interval | Sample sizes | Pooled correlations between the 2 outcomes | Differences in SMC | Sampling variance | Sampling covariance | |||||||||||||||||||||
|
| Control | Intervention | Control | Intervention |
| Control | Intervention | ||||||||||||||||||||||
|
| |||||||||||||||||||||||||||||
|
| BBSb | 0.2752 | 0.6691 | 0.5347075 | 0.8318219 | 1.3679 | 10 | 11 | 0.6482 | 0.2879 | 0.1929 | 0.1235 | |||||||||||||||||
|
| TUGc | −0.1982 | −0.3870 | 0.4264936 | 0.7023536 | 2.3817 | 10 | 11 | 0.6482 | −0.0792 | 0.1911 | 0.1235 | |||||||||||||||||
|
| |||||||||||||||||||||||||||||
|
| BBS | 1.3922 | 0.9171 | 0.9558409 | 0.8978624 | 1.7163 | 9 | 9 | 0.6482 | −0.2768 | 0.2244 | 0.1452 | |||||||||||||||||
|
| TUG | −0.5768 | −1.1695 | 0.7852951 | 0.9161890 | 1.6490 | 9 | 9 | 0.6482 | −0.3594 | 0.2258 | 0.1452 | |||||||||||||||||
|
| |||||||||||||||||||||||||||||
|
| BBS | 0.3472 | 0.5847 | 0.7299132 | 0.9078490 | 0.2180 | 18 | 16 | 0.7069 | 1.0895 | 0.1355 | 0.0548 | |||||||||||||||||
|
| TUG | −0.2495 | −0.6736 | 0.5644717 | 0.9050366 | 0.1187 | 18 | 16 | 0.7069 | −3.5745 | 0.3060 | 0.0548 | |||||||||||||||||
|
| |||||||||||||||||||||||||||||
|
| BBS | 0.7142 | 1.0501 | 0.8919225 | 0.9560710 | 0.9351 | 11 | 10 | 0.7069 | 0.3593 | 0.1940 | 0.1940 | |||||||||||||||||
aSMC: standardized mean test.
bBBS: Berg Balance Scale.
cTUG: Timed Up and Go.
Figure 2Forest plot. AR: augmented reality; SMCR: standardized mean change with raw standardization; BBS: Berg Balance Scale; TUG: Timed Up and Go.
Figure 3Weights and sample size of each study. SMC: standardized mean change; AR: augmented reality; BBS: Berg Balance Scale; TUG: Timed Up and Go.
Figure 4Variance components.
Figure 5Funnel plot of the standardized mean change versus the standard error.